An interventional study of Dialectic Behavioural Therapy in Autism Spectrum Disorder, sponsored by GGZ Friesland. Recruiting at 1 site in Netherlands. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-08-26.
Sponsored by GGZ Friesland · Not applicable, Interventional, and Treatment
The goal of this experimental study is to test the effectiveness of Dialectic Behavioural Therapy in patients with Autism Spectrum Disorder. The aim questions are:
Participants will:
Exclusion Criteria:
Dialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder, given for 10 months
Behavioral: Dialectic Behavioural Therapy
Dialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder
Maladaptive Emotion Regulation Strategies (MERS) measured assessed by the DBT diary (Linehan, 2016)
MERS is the average of the urge to six maladaptive emotion regulation strategies: 1. suicidal thoughts/behaviours 2. self-harm, 3. eating problems 4. substance abuse 5. anger outburst 6. other All emotion regulation strategies are measured on a scale from 0 - 100. MERS will be created by adding scores of the six strategies together and divide it by 6.
Time frame: From enrollment to end of treatment at 10 months
Emotional well-being as assessed by the DBT diary (Linehan, 2016)
The daily diary measures emotional suffering and happiness on a scale from 0 - 100. Emotional suffering is inverted, following the logic that higher emotional suffering means lower emotional well-being. The variable well-being is created by averaging the invert of emotional suffering and happiness.
Time frame: From enrollment to end of treatment at 10 months
Social behaviour
As measured by the Vragenlijst Inventarisatie van Sociaal gedrag bij Volwassenen (VIS-V) (Horwitz et al. 2013). The VIS-V is a 44-item questionnaire that assess social behaviour, with answers ranging from 0 (= not applicable) to 2 (=cleary applicable). Higher scores mean lower social behaviour.
Time frame: At start of baseline (T1), at end of treatment phase at 10 months (T2)
Emotion regulation
As measured with the Difficulties in Emotion Regulation Scale (DERS) (Gratz \& Roemer, 2004). The DERS is a 36-item questionnaire with 5-point Likert answers, ranging from "almost never" to "almost always".
Time frame: At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
Generic psychopathology and functioning
As measured with the Outcome Questionnaire-45 (OQ-45) (De Jong et al., 2008). The OQ-45 is a 45-item questionnaire, with answers ranging from never (0) to almost always (4). Some items are mirrored.
Time frame: At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
Documents are hosted by the registry — open the source record to download them.
Plan to share: No — To protect the participants of the study
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.